Nicholas C. Wolff

1.8k total citations
15 papers, 1.2k citations indexed

About

Nicholas C. Wolff is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Nicholas C. Wolff has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Hematology. Recurrent topics in Nicholas C. Wolff's work include Renal cell carcinoma treatment (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Nicholas C. Wolff is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Nicholas C. Wolff collaborates with scholars based in United States, Russia and Austria. Nicholas C. Wolff's co-authors include Robert Ilaria, James Brugarolas, Xian‐Jin Xie, Silvia Vega-Rubín-de-Celis, Tram Anh T. Tran, Samuel Peña‐Llopis, Jacob C. Schwartz, Lihua Zou, David R. Corey and Merrill J. Egorin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Nicholas C. Wolff

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas C. Wolff United States 14 684 328 264 244 232 15 1.2k
Abdullah Mahmood Ali United States 20 1.5k 2.2× 90 0.3× 319 1.2× 128 0.5× 309 1.3× 60 2.0k
Martin Janz Germany 23 1.3k 1.9× 132 0.4× 235 0.9× 104 0.4× 400 1.7× 47 2.5k
Michele Massimino Italy 22 496 0.7× 131 0.4× 316 1.2× 68 0.3× 249 1.1× 64 1.2k
Jana Karásková Canada 17 870 1.3× 108 0.3× 147 0.6× 56 0.2× 333 1.4× 22 1.4k
Elena Tirrò Italy 19 423 0.6× 123 0.4× 265 1.0× 69 0.3× 207 0.9× 48 1.0k
Françoise Cormier France 18 693 1.0× 305 0.9× 246 0.9× 28 0.1× 173 0.7× 32 1.3k
Meaghan Wall Australia 23 983 1.4× 153 0.5× 266 1.0× 45 0.2× 166 0.7× 57 1.6k
Robert W. Schnepp United States 18 1.0k 1.5× 255 0.8× 91 0.3× 598 2.5× 288 1.2× 37 2.0k
Gunhild Trøen Norway 21 439 0.6× 68 0.2× 160 0.6× 72 0.3× 133 0.6× 46 1.1k
Diana Linnekin United States 23 839 1.2× 161 0.5× 547 2.1× 41 0.2× 90 0.4× 40 2.0k

Countries citing papers authored by Nicholas C. Wolff

Since Specialization
Citations

This map shows the geographic impact of Nicholas C. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas C. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas C. Wolff more than expected).

Fields of papers citing papers by Nicholas C. Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas C. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas C. Wolff. The network helps show where Nicholas C. Wolff may publish in the future.

Co-authorship network of co-authors of Nicholas C. Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas C. Wolff. A scholar is included among the top collaborators of Nicholas C. Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas C. Wolff. Nicholas C. Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Christie, Alana, Tiffani McKenzie, Nicholas C. Wolff, et al.. (2017). Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Cancer Discovery. 7(8). 900–917. 110 indexed citations
2.
Hwang, Seonghwan, Youngah Jo, Nicholas C. Wolff, James Brugarolas, & Russell A. DeBose‐Boyd. (2017). HIF‐1a‐Mediated Induction of Insig‐2 Regulates Cholesterol Metabolism by Accelerating Degradation of HMGCR. The FASEB Journal. 31(S1). 1 indexed citations
3.
Wolff, Nicholas C., Andrea Pavía-Jiménez, Vanina Toffessi Tcheuyap, et al.. (2015). High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma. Oncotarget. 6(19). 16951–16962. 25 indexed citations
4.
Wolff, Nicholas C., Renée M. McKay, & James Brugarolas. (2014). REDD1/DDIT4-Independent mTORC1 Inhibition and Apoptosis by Glucocorticoids in Thymocytes. Molecular Cancer Research. 12(6). 867–877. 24 indexed citations
5.
Wang, Shanshan, Nicholas C. Wolff, Karoliina Stefanius, et al.. (2014). Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proceedings of the National Academy of Sciences. 111(46). 16538–16543. 111 indexed citations
6.
Kucejová, Blanka, Samuel Peña‐Llopis, Toshinari Yamasaki, et al.. (2011). Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma. Molecular Cancer Research. 9(9). 1255–1265. 86 indexed citations
7.
Peña‐Llopis, Samuel, Silvia Vega-Rubín-de-Celis, Jacob C. Schwartz, et al.. (2011). Regulation of TFEB and V-ATPases by mTORC1. The EMBO Journal. 30(16). 3242–3258. 365 indexed citations
8.
Wolff, Nicholas C., Silvia Vega-Rubín-de-Celis, Xian‐Jin Xie, et al.. (2011). Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia. Molecular and Cellular Biology. 31(9). 1870–1884. 62 indexed citations
9.
Wolff, Nicholas C., Wareef Kabbani, Thomas Bradley, et al.. (2010). Sirolimus and Temsirolimus for Epithelioid Angiomyolipoma. Journal of Clinical Oncology. 28(5). e65–e68. 49 indexed citations
10.
Ye, Dan, Nicholas C. Wolff, Li Li, Shumin Zhang, & Robert Ilaria. (2006). STAT5 signaling is required for the efficient induction and maintenance of CML in mice. Blood. 107(12). 4917–4925. 90 indexed citations
11.
Wolff, Nicholas C., Darren R. Veach, William P. Tong, et al.. (2005). PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Blood. 105(10). 3995–4003. 51 indexed citations
12.
Wolff, Nicholas C., et al.. (2004). Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer. Clinical Cancer Research. 10(10). 3528–3534. 49 indexed citations
13.
Wolff, Nicholas C., James A. Richardson, Merrill J. Egorin, & Robert Ilaria. (2003). The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia. Blood. 101(12). 5010–5013. 82 indexed citations
14.
Wolff, Nicholas C. & Robert Ilaria. (2001). Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571. Blood. 98(9). 2808–2816. 76 indexed citations
15.
Silvany, Robert, Susan Eliazer, Nicholas C. Wolff, & Robert Ilaria. (2000). Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation. Oncogene. 19(39). 4523–4530. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdullah Mahmood Ali Breakdown of academic impact, for papers by Martin Janz Breakdown of academic impact, for papers by Michele Massimino Breakdown of academic impact, for papers by Jana Karásková Breakdown of academic impact, for papers by Elena Tirrò Breakdown of academic impact, for papers by Françoise Cormier Breakdown of academic impact, for papers by Meaghan Wall Breakdown of academic impact, for papers by Robert W. Schnepp Breakdown of academic impact, for papers by Gunhild Trøen Breakdown of academic impact, for papers by Diana Linnekin
Rankless by CCL
2026